Bioheart CEO Mike Tomas Honored for Community and

New Post Public Reply Private Reply Replies (1) Message Board
junewong

Bioheart CEO Mike Tomas Honored for Community and Business Endeavors

Bioheart, Inc. (NASDAQ:BHRT)
Intraday Stock Chart

Today : Monday 25 March 2013

Click Here for more Bioheart, Inc. Charts.

Bioheart, Inc. (OTCQB: BHRT) announced today that Mike Tomas, the Company's President/CEO has received multiple accolades and honors from both national and international assemblages.

This past Saturday Mr. Tomas attended the 12th Annual Torch Awards at Florida International University (FIU). He was bestowed FIU's highest honor; the 2013 Torch Award for lifetime business, community leadership and civic involvement.  https://fiualumni.com/torch2013/

He was also nominated for the 2013 Ernst & Young Entrepreneur of the Year award. The award is considered the world's most prominent business award for entrepreneurs.  http://www.ey.com/US/en/About-us/Entrepreneur...f-The-Year

This June Mr. Tomas will be presented the 2013 Father of the Year award by the American Diabetes Association (ADA). Each year the ADA recognizes men from the U.S.A. for the outstanding strength, commitment and love they exhibit as fathers.  http://main.diabetes.org/site/PageServer?page...=MikeTomas

"I am sincerely honored to be recognized by these exceptional organizations. I endeavor to make a positive difference in the lives of others and to push forward on opportunities," said Mr. Tomas.

In the past year, Mike Tomas was inducted into the Miami Dade College Hall of Fame and welcomed into the World Assembly and Council (WACE) Hall of Fame.

Dr. William P. Murphy Jr., Chairman of the Board commented, "Bioheart is fortunate to have someone of Mike's caliber leading our company. His business acumen has been proven time and again throughout his career. He has led his many business ventures to success and I feel confident that Bioheart will be no exception."

About Bioheart, Inc.

Bioheart is committed to maintaining its leading position within the cardiovascular sector of the cell technology industry delivering cell therapies and biologics that help address congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarctions and other issues. Bioheart's goals are to cause damaged tissue to be regenerated, when possible, and to improve a patient's quality of life and reduce health care costs and hospitalizations.

Specific to biotechnology, Bioheart is focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease. Its leading product, MyoCell, is a clinical muscle-derived cell therapy designed to populate regions of scar tissue within a patient's heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients. For more information on Bioheart, visit  www.bioheartinc.com , or visit us on Facebook: Bioheart and Twitter  @BioheartInc .

About Mike Tomas 

Mike Tomas was appointed as Bioheart's President, CEO and a Director on June 19, 2010. For the past 11 years, he has served as President of The ASTRI Group, an early stage private equity investment company in Florida with an investment in Bioheart. In 2003, he joined Bioheart's Board of Directors as the independent representative of The ASTRI Group. Prior to this, Tomas held ascending executive positions including Chief Marketing Officer at Avantel, a $1 billion dollar joint venture with MCI. He currently sits on the boards of Perimeter Internetworking, Avisena and Total Home Health. He is also the current chairman of the Global Entrepreneurship Center at Florida International University and a founding coach/mentor at the University of Miami's Launch Pad at the Toppel Center. Mike holds a Masters of Business Administration from the University of Miami, a Bachelor degree from Florida International University and an Associate degree from Miami Dade College.

Forward-Looking Statements: Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "to," "plan," "expect," "believe," "anticipate," "intend," "could," "would," "estimate," or "continue" or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements.

Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management's beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

The Company is subject to the risks and uncertainties described in its filings with the Securities and Exchange Commission, including the section entitled "Risk Factors" in its Annual Report on Form 10-K for the year ended December 31, 2011, and its Quarterly Report on Form 10-Q for the quarter ended September 30, 2012.

Bioheart, Inc.

13794 NW 4th Street

Suite 212

Sunrise, FL 33325

Telephone 954-835-1500

Email:  rmadaris@bioheartinc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading

Top 5 Most Recently Viewed Articles

LBMC’s 40-Year Journey: Transforming Business and Community

Updated Category News Views 214

Celebrating 40 Years of Excellence at LBMC In the summer of 1984, a passionate group of 12 visionaries in the business consulting field came together to create something special. Their mission was clear: to build a firm where clients would be treated like partners, and innovation would emerge from genuine customer needs. This strong community-oriented culture gave birth...

Continue Reading
Equinor's 2024 Annual Report Highlights Key Developments

Updated Category News Views 1158

Equinor’s 2024 Annual Report Unveils Key Insights The latest stock market announcement serves as a correction regarding the presentation of Equinor ASA's financial data within the annual report. The previous version was deemed insufficient, and this notice aims to clarify and present the complete balance sheet data correctly. Equinor ASA (OSE: EQNR, NYSE: EQNR) has...

Continue Reading
Silo Pharma Sets Course with New Cryptocurrency Investments

Updated Category News Views 120

Silo Pharma's Strategic Shift Towards Cryptocurrency Investments Strategic capital deployment advances Company’s blockchain treasury model and biopharma development initiatives. Silo Pharma, Inc. (NASDAQ: SILO) has recently taken a significant step in its financial strategy by announcing its initial investment in cryptocurrency. This move is part of their broader...

Continue Reading
Crucial Steps for EPSO-G's Upcoming Extraordinary Meeting

Updated Category News Views 53

Understanding EPSO-G's Extraordinary General Meeting EPSO-G, a key player in the energy sector, has taken an important step by convening an Extraordinary General Meeting (EGM). This decision was initiated by the Board of Energy Transmission and Exchange Group EPSO-G, representing a significant moment for the organization and its stakeholders. Purpose of the Meeting The...

Continue Reading
Innovative Wearable Blanket Revolutionizes Comfort and Warmth

Updated Category News Views 296

In a landscape where staying warm is crucial, the HEAT WRAP emerged back in 2024 as a revolutionary solution. Designed to replace bulky blankets and traditional heating methods, it captures the market's attention by promoting freedom of movement while ensuring coziness. Traders eyeing this innovation saw potential disruption in established heating alternatives; you could...

Continue Reading